Catheter Precision (VTAK) Depreciation & Amortization (CF) (2017 - 2026)

Catheter Precision (VTAK) has 10 years of Depreciation & Amortization (CF) data on file, last reported at $405000.0 in Q1 2026.

• On a quarterly basis, Depreciation & Amortization (CF) fell 23.73% year-over-year to $405000.0 in Q1 2026; TTM through Mar 2026 was $2.0 million, a 6.09% decrease from a year earlier, with the FY2025 full-year figure at $2.1 million, changed 0.28% from the prior year.
• Depreciation & Amortization (CF) for Q1 2026 stood at $405000.0, down from $527000.0 in the prior quarter.
• Over the last five years, Depreciation & Amortization (CF) for VTAK reached as high as $1.4 million in Q1 2023 and fell as low as -$406000.0 in Q2 2023.
• Historically, Depreciation & Amortization (CF) has averaged $419117.6 across 5 years, with a median of $522000.0 in 2024.
• On a YoY basis, Depreciation & Amortization (CF) climbed as much as 1968.0% in 2023 and fell as far as 398.53% in 2023.
• Year by year, Depreciation & Amortization (CF) stood at $25000.0 in 2022, then surged by 1968.0% to $517000.0 in 2023, then advanced by 2.71% to $531000.0 in 2024, then slipped by 0.75% to $527000.0 in 2025, then dropped by 23.15% to $405000.0 in 2026.
• Per Business Quant data, the three most recent Depreciation & Amortization (CF) figures were $405000.0 in Q1 2026, $527000.0 in Q4 2025, and $528000.0 in Q3 2025.